| References1Meissner, H.I., et al. Promoting cancer screening: Learning from experience. Cancer 101 (Suppl 5):1107–1117, 2001. More information available at www3.interscience.wiley.com/cgi-bin/jissue/109594949; accessed October 31, 2006. 2 Breen, N., and Meissner, H.I. Toward a system of cancer screening in the United States: Trends and opportunities. Annual Review of Public Health 26:561–582, 2005. More information available at http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.publhealth.26.021304.144703; accessed October 31, 2006. 3Centers for Disease Control and Prevention (CDC). The National Breast and Cervical Cancer Early Detection Program 1991–2002 National Report. Atlanta, GA: U.S. Department of Health and Human Services (HHS), 2005. More information available at www.cdc.gov/cancer/nbccedp/Reports/NationalReport/index.htm; accessed October 31, 2006. 4Coates, R.J., et al., eds. A collaborative, comprehensive approach to fulfilling the promise of cancer prevention and control. Cancer Causes and Control 16(Suppl 1):1–88, 2005. 5Harris, R., and Lohr, K.N. Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 137(11):917–929, 2002. More information available at www.annals.org/cgi/content/full/137/11/917; accessed October 31, 2006. 6U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. Rockville, MD: Agency for Healthcare Research and Quality, 2002. More information available at www.ahrq.gov/clinic/cps3dix.htm; accessed October 31, 2006. 7Albertsen, P.C. The prostate cancer conundrum. Journal of the National Cancer Institute 95(13):930–931, 2003. More information available at http://jncicancerspectrum.oxfordjournals.org/cgi/content/full /jnci;95/13/930; accessed October 31, 2006. 8Wilt, T.J., and Brawer, M.K. The Prostate Cancer Intervention Versus Observation Trial (PIVOT). Oncology (Williston Park) 11(8):1133–1139, 1997. 9Andriole, G.L., et al. Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: Findings from the initial screening round of a randomized trial. Journal of the National Cancer Institute 97(6):433–438, 2005. More information available at http://jncicancerspectrum.oxfordjournals.org/cgi/content/full/jnci;97/6/433; accessed October 31, 2006. 10de Koning, H.J., et al. Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC). International Journal of Cancer 98(2):268–273, 2002. 11Wingo, P.A., et al. Annual report to the nation on the status of cancer, 1973–1996, with a special section on lung cancer and tobacco smoking. Journal of the National Cancer Institute 91(8):675–690, 1999. More information available at http://jncicancerspectrum.oxfordjournals.org/cgi/content/full/jnci;91/8/675; accessed October 31, 2006. 12Husten, C., and Thorne, S. Tobacco: Health effects and control. In Wallace, R.B., ed. Maxcy-Rosenau-Last Public Health & Preventive Medicine, 15th ed. Stamford, CT: Appleton & Lange (in press). 13HHS. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, GA: HHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2000. More information available at www.cdc.gov/tobacco/sgr/sgr_2000; accessed October 31, 2006. 14Swan, J., et al. Progress in cancer screening practices in the United States: Results from the 2000 National Health Interview Survey. Cancer 97(6):1528–1540, 2003. 15National Cancer Institute (NCI). NCI's Cancer Intervention and Surveillance Modeling Network (CISNET). More information available at http://cisnet.cancer.gov; accessed October 31, 2006. 16Berry, D.A., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine 353(17):1784–1792, 2005. 17CDC. Cancer survivorship─United States, 1971–2001. Morbidity and Mortality Weekly Report 53(24):526–529, 2004. More information available at www.cdc.gov/mmwr/PDF/wk/mm5324.pdf; accessed October 31, 2006. 18Curry, S.J., et al., eds. Institute of Medicine (IOM). Fulfilling the Potential of Cancer Prevention and Early Detection. Washington, DC: National Academies Press: 2003. More information available at www.iom.edu/report.asp?id=5402; accessed October 31, 2006. 19Hewitt, M., and Simone, J.V., eds. IOM. Ensuring Quality Cancer Care. Washington, DC: National Academy Press; 1999. More information available at www.nap.edu/books/0309064805/html; accessed October 31, 2006. 20Welch, H.G. Are increasing 5-year survival rates evidence of success against cancer? Journal of the American Medical Association 283(22):2975–2978, 2002. 21Wingo, P.A., et al. Building the infrastructure for nationwide cancer surveillance and control: A comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes and Control 14:175–193, 2003. 22Task Force on Community Preventive Services. The Guide to Community Preventive Services: Cancer Prevention and Control. More information available at www.thecommunityguide.org/cancer; accessed October 31, 2006. 23Seeff, L.C., et al. Increased use of colorectal cancer test—United States, 2002 and 2004. Morbidity and Mortality Weekly Report 55(11):308–311, 2006. 24CDC, Division of Cancer Prevention and Control (DCPC). Cancer Prevention and Control. More information available at www.cdc.gov/cancer; accessed October 31, 2006. 25Cancer Control PLANET. Available at cancercontrolplanet.cancer.gov/index.html; accessed October 31, 2006. 26International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. More information available at http://monographs.iarc.fr; accessed October 31, 2006. 27CDC, DCPC. Skin Cancer Primary Prevention and Education Initiative. More information available at www.cdc.gov/cancer/nscpep/index.htm; accessed October 31, 2006. 28Grimshaw, J.M., et al. Changing provider behavior: An overview of systematic reviews of interventions. Medical Care 39(8 Suppl 2):II2–II45, 2001. 29National Institutes of Health (NIH). Cervical cancer. National Institutes of Health Consensus Statement 14(1):1–38, 1996. 30Harper, S., and Lynch, J. Methods for Measuring Cancer Disparities: A Review Using Data Relevant to Healthy People 2010 Cancer-Related Objectives. NCI Cancer Surveillance Monograph Series, No. 6. NIH Publication No. 05-5777. Bethesda, MD: NCI, 2005. 31Trans-HHS Cancer Health Disparities Progress Review Group. Making Cancer Health Disparities History. Submitted to the Secretary, HHS, March 2004. Washington, DC: HHS. More information available at www.chdprg.omhrc.gov/pdf/chdprg.pdf; accessed October 31, 2006. 32Krieger, N. Theories for social epidemiology in the 21st century: An ecosocial perspective. International Journal of Epidemiology 30(4):668–677, 2001. 33Health Resources and Services Administration. Health Disparities Collaboratives. Cancer Collaborative. More information available at www.healthdisparities.net/hdc/html/collaboratives.topics.cancer.aspx; accessed October 31, 2006. 34National Business Group on Health. Improving Health, Improving Business: The Employer's Guide to Health Improvement and Preventive Services. More information available at www.wbgh.org/services/index.cfm; accessed October 31, 2006. 35National Committee for Quality Assurance. The State of Health Care Quality 2005: Industry Trends and Analysis. Washington, DC: NCQA; 2005. More information available at www.ncqa.org/Docs/SOHCQ_2005.pdf; accessed October 31, 2006. 36C-Change. More information available at www.c-changetogether.org; accessed October 31, 2006. 37Chattopadhyay, S.K., Sources of health insurance in the U.S.: Analysis of state-level data and implications for public health programs. Journal of Public Health Management and Practice 5:35–46, 1996. 38Kerner, J.F., et al. Translating research into improved outcomes in comprehensive cancer control. Cancer Causes and Control 16(Suppl 1):27–40, 2005. 39National Quality Forum. Quality of Cancer Care Measures Project: Phase II. More information available at www.qualityforum.org/projects/ongoing/cancer/index.asp; accessed October 31, 2006. Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®. << Previous—Objectives and Subobjectives | Table of Contents | Next—Related Objectives From Other Focus Areas >> |